Month: April 2018

NCPA Advocacy Center Update – Week Ending April 27, 2018

NCPA Efforts Result in Key Pharmacy Protections in Senate and House Opioid Bills This week, both chambers of Congress took the first steps in advancing legislation to address the opioid crisis. The Senate Health, Education, Labor, and Pensions (HELP) Committee

Consumer Confidential: They’re called ‘co-pay accumulators,’ and they’re a way insurers make you pay more for meds

Mary Hawley takes the widely used drug Humira for her rheumatoid arthritis. It can cost tens of thousands of dollars a year, but for nearly a decade Hawley has been assisted with discount coupons from the drug’s manufacturer, AbbVie.  “You

FDA Drug Safety Communication: FDA warns of serious immune system reaction with seizure and mental health medicine lamotrigine (Lamictal)

The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout

Webinar on Prescription Drugs and Heroin

WEBINAR – REGISTER NOW PRESCRIPTION DRUGS AND HEROIN Thursday, April 26, 2018 2:00 p.m. to 3:00 p.m. ET I 1:00 p.m. to 2:00 p.m. CT The opioid epidemic is having an ongoing serious impact on communities throughout the United States.

How will the new tax laws affect your business?

Are you up on how the new tax law will affect small business like yours? Sign up for this webinar by Ollin Sykes, CPA with Sykes & Co., to make sure you’re up to date. This webinar will help you

NCPA Advocacy Center Update – Week Ending April 20, 2018

NCPA Introduces MedPAC Nominee to Key Hill Staff This week NCPA government affairs staff accompanied NCPA’s Medicare Payment Advisory Commission (MedPAC) nominee Troy Trygstad to meetings with staff from key Congressional committees that have jurisdiction over Medicare. These included discussions

NCPA Advocacy Center Update – Week Ending April 6, 2018

NCPA Congressional Pharmacy Summit Only Days Away The NCPA Congressional Pharmacy Summit is days away. Registration is available onsite for anyone who has not yet registered but still wants to take advantage of several CE opportunities as we provide you

Special NCPA Advocacy Center Update- CMS Issues Final 2019 Medicare Part D Rule and Call Letter

On April 2, 2018 The Centers for Medicare & Medicaid Services released their final Part D Rule and final Call Letter for 2019 Medicare Part D and Medicare Advantage plans. NCPA is conducting a thorough analysis of each and will

Advocates Urge Congress to Include Provider Status Bill

NACDS RxIMPACT launched an all-out letter-writing campaign the week of March 26, urging pharmacy advocates to spotlight the value of H.R. 592, The Pharmacy and Medically Underserved Areas Enforcement Act. Advocates should ask their representatives to include the legislation in

NCPA Advocacy Center Update – Week Ending March 30, 2018

Online Registration Deadline Fast Approaching for NCPA Congressional Pharmacy Summit The deadline to register online for the NCPA Congressional Pharmacy Summit is Wednesday April 4.  Any registrations after that date must be done on site. Don’t miss the opportunity to